Author:
Kesavadev Jothydev,Saboo Banshi,Benny Nelena,Basanth Anjana,Krishnan Gopika,Shankar Arun,Jothydev Sunitha
Abstract
In people with diabetes, the most efficient therapeutic option available to reduce hyperglycemia continues to be insulin, even though they experience numerous challenges with the use of insulin. Beginning with the syringe for injecting insulin, progressing to insulin pens, insulin pumps, and sensor-augmented pumps, the growth of diabetes technologies accelerated with the introduction of hybrid closed-loop systems, integration with consumer electronics, and cloud-based data systems. There has been a high-speed evolution in diabetes technologies to improve the quality of life and to extend the endurance of subjects with diabetes. Although there were commendable developments in the currently available devices, many of those were prohibitively expensive. The ultimate dream is to develop an artificial pancreas capable of 100% time in range and 0% time below range and affordable to everyone. Even though the mission demands enormous commitment and time, it has the potential to transform diabetes therapy.